OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients
Rui Li, Xiaobo Sun, Yaqing Shu, et al.
Journal of Neuroimmunology (2017) Vol. 313, pp. 56-60
Closed Access | Times Cited: 25

Showing 25 citing articles:

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
Pan Shen, Xuan Deng, Zhe Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 106

The role of chemokines and chemokine receptors in multiple sclerosis
Liyuan Cui, Shifeng Chu, Naihong Chen
International Immunopharmacology (2020) Vol. 83, pp. 106314-106314
Open Access | Times Cited: 100

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
Matija Zelic, Fabrizio Pontarelli, Lisa Woodworth, et al.
Cell Reports (2021) Vol. 35, Iss. 6, pp. 109112-109112
Open Access | Times Cited: 91

A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis
Soudeh Ghafouri‐Fard, Kasra Honarmand, Mohammad Taheri
Metabolic Brain Disease (2021) Vol. 36, Iss. 3, pp. 375-406
Closed Access | Times Cited: 34

Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity
Doryssa Hermans, Evelien Houben, Paulien Baeten, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 2, pp. 259-281
Closed Access | Times Cited: 23

Regulatory role of DBC1 in inflammation and autoimmune diseases
Jinzhi Wu, Fan Yang, Guanhua Xu, et al.
Rheumatology & autoimmunity (2025)
Open Access

Serum SIRT1 is Associated with Frailty and Adipokines in Older Adults
Lina Ma, Hongxin Niu, Guiming Sha, et al.
The journal of nutrition health & aging (2018) Vol. 23, Iss. 3, pp. 246-250
Open Access | Times Cited: 28

Reduced serum SIRT1 levels in patients with Parkinson’s disease: a cross-sectional study in China
Yuting Zhu, Xiangyang Zhu, Yong Zhou, et al.
Neurological Sciences (2020) Vol. 42, Iss. 5, pp. 1835-1841
Closed Access | Times Cited: 21

Increased levels of sirtuin‐1 in systemic lupus erythematosus
Chan Yang, Rong Li, Wang‐Dong Xu, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 8, pp. 869-876
Closed Access | Times Cited: 13

Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia
Ülkan Kılıç, Birsen Elibol, Ömer Uysal, et al.
Experimental Gerontology (2018) Vol. 111, pp. 203-209
Closed Access | Times Cited: 20

NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway
Jinli Wang, Xueqin Song, Guo-Jun Tan, et al.
Aging (2021) Vol. 13, Iss. 24, pp. 25931-25943
Open Access | Times Cited: 12

Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities
Forough Foolad, Fariba Khodagholi, Seyed Massood Nabavi, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230691-e0230691
Open Access | Times Cited: 12

Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein–Barr Virus
Jelena Košćak Lukač, Koraljka Bačić Baronica, Alan Šućur, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8064-8064
Open Access | Times Cited: 1

Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments
Forough Foolad, Zahra Samadi‐Bahrami, Fariba Khodagholi, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3442-3460
Closed Access | Times Cited: 3

Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview
Meysam Moghbeli
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 1, pp. 65-85
Closed Access | Times Cited: 5

Cytokines and Chemokines in the Nervous System in Health and Disease
Gholamreza Azizi, Abdolmohamad Rostami
Elsevier eBooks (2024)
Closed Access

Chemokines in neurodegenerative diseases
Hashemi Vida, Mehranfar Sahar, Amin Nikdouz, et al.
Immunology and Cell Biology (2024)
Closed Access

Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis
İsmail Peker, Hacer Eroğlu İçli, Belgin Mutluay, et al.
Biomedicines (2024) Vol. 13, Iss. 1, pp. 40-40
Open Access

Global DNA Methylation and Hydroxymethylation Levels in PBMCs Are Altered in RRMS Patients Treated with IFN-β and GA—A Preliminary Study
María Paulina Reyes-Mata, Mario Alberto Mireles-Ramírez, Christian Griñán‐Ferré, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9074-9074
Open Access | Times Cited: 1

Multiple Sclerosis in Patients with Intracranial Aneurysms: Coincidence or Correlation?
Melanie Walker, Christopher C. Young, Michael R. Levitt, et al.
Clinical Neurology and Neurosurgery (2020) Vol. 195, pp. 105864-105864
Open Access | Times Cited: 2

Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders
Lu Zhang, Yumei Xue, Congcong Yuan, et al.
Acta Neurologica Belgica (2023) Vol. 123, Iss. 6, pp. 2287-2294
Closed Access

Association study of CCL20 rs6749704 with Rheumatoid Arthritis in Iraqi population
Aya Kamil, Mahmoud Mouhammad, Al-Halbosiy Farhan, et al.
Journal of Pharmaceutical Negative Results (2022) Vol. 13, Iss. S01
Open Access

Page 1

Scroll to top